Paylocity Holding Corp

During the three months ended December 31, 2024, the following directors and/or officers (as defined in Rule 16a-1(f))adopted a “Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K intending to satisfy the affirmative defense of Rule 10b5-1(c):

(1) The trading arrangement permits transactions through and including the earlier to occur of (a) the completion of all sales or (b) the expiration date listed in the table.

(2) Mr. Beauchamp’s Rule 10b5-1 trading arrangement includes 120,000 shares held directly by Mr. Beauchamp and 22,500 shares to be sold by the IRIE Foundation, over which Mr. Beauchamp has voting and dispositive power.

(3) The number of shares to be sold is determined, in part, based on pricing triggers outlined in the adopting person's trading arrangement.

(4) Includes shares subject to certain outstanding equity awards with time- and/or performance-based vesting conditions. For shares subject to performance-based vesting conditions, the number of shares included in the table above assumes the target achievement of the performance-based conditions. Additionally, for both time- and performance-based vesting awards, the actual number of shares that may be sold will be net of the number of shares withheld by the Company to satisfy tax withholding obligations arising from the vesting of such awards, which is not determinable at this time.

(5) The trading arrangement was entered into by Jessica Sarowitz, Mr. Sarowitz’s spouse.

No directors or officers terminated a Rule 10b5-1 trading arrangement or entered into orterminated a “non-Rule 10b5-1 trading arrangement” as defined in Item 408(a) of Regulation S-K during the three months ended December 31, 2024.